Dr. Tucker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6120 Rockville Pike
Bethesda, MD 20892Phone+1 301-496-4375Fax+1 301-402-4489
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1981 - 1983- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1976 - 1978
Harvard Medical SchoolClass of 1976
Certifications & Licensure
MD State Medical License 1989 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer Start of enrollment: 1985 Apr 02
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma Start of enrollment: 2002 Jul 01
Publications & Presentations
PubMed
- 1652 citationsThe Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi JewsJeffery P. Struewing, Patricia Hartge, Sholom Wacholder, Sonya M. Baker, Martha Berlin
The New England Journal of Medicine. 1997-05-15 - 131 citationsRisk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary RetinoblastomaRuth A. Kleinerman, Margaret A. Tucker, David H. Abramson, Johanna M. Seddon, Robert E. Tarone
Journal of the National Cancer Institute. 2007-01-03 - 105 citationsEnvironment And Genetics in Lung cancer Etiology (EAGLE) study: An integrative population-based case-control study of lung cancerMaria Teresa Landi, Dario Consonni, Melissa Rotunno, Andrew W. Bergen, Alisa M. Goldstein
BMC Public Health. 2008-06-06
Journal Articles
- ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum ConsortiumMargaret Tucker, MD, Journal of The European Academy of Dermatology and Venereology
Grant Support
- Family StudiesNational Cancer Institute2010–2011
- Applied Molecular Pathology LaboratoryNational Cancer Institute2010–2011
- Family StudiesDivision Of Cancer Epidemiology And Genetics2009
- Family StudiesNational Cancer Institute2007–2008
- Family StudiesDivision Of Cancer Epidemiology And Genetics1997–2006
- LATE Effects Of Cancer TreatmentDivision Of Cancer Epidemiology And Genetics1999–2004
- Neoplasm Epidemiology: Family StudiesDivision Of Cancer Epidemiology And Genetics2001
- LATE EffectsDivision Of Cancer Epidemiology And Genetics1997
- Studies Of Persons At High Risk Of Cancer--Genetic EpidemiologyDivision Of Cancer Epidemiology And Genetics1996
- Studies Of Persons At High Risk Of Cancer--Family StudiesDivision Of Cancer Epidemiology And Genetics1996
- Studies Of Persons At High Risk Of Cancer--Pharmacogenetic StudiesDivision Of Cancer Epidemiology And Genetics1995–1996
- Studies Of Persons At High Risk Of Cancer--Late EffectsDivision Of Cancer Epidemiology And Genetics1995–1996
- Studies Of Persons At High Risk Of Cancer--Genetic EpidemiologyDivision Of Cancer Epidemiology And Genetics1995
- Studies Of Persons At High Risk Of Cancer--Family StudiesDivision Of Cancer Epidemiology And Genetics1995
- Studies Of Persons At High Risk Of CancerDivision Of Cancer Epidemiology And Genetics1986–1994
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
